Leuprorelin acetate
Leuprorelin acetate was ranked 388th of 1,792 medicines by items in May 2026, with 20,279 items, down 9.4% on a year earlier.
Dispensed in May 2026
Rolling 12 months
Net ingredient cost · May 2026
Figure 1. Leuprorelin acetate: national items dispensed by month
Source: NHSBSA Prescription Cost Analysis, to May 2026
Embed this chart
At a glance
- Therapeutic class Sex hormones and hormone antagonists in malignant disease
- Presentations 5 shown
- Average cost / item £196.29
- Year on year Down 9.4% on a year earlier
Top presentations, May 2026
The individual products dispensed under Leuprorelin acetate this month.
| Presentation | BNF code | Items | Net ingredient cost |
|---|---|---|---|
| Prostap 3 DCS 11.25mg pdr and solvent for prolonged-rel inj | 0803042N0BBADAD | 15,966 | £3,613,551 |
| Prostap SR DCS 3.75mg pdr and solvent for prolonged-rel inj | 0803042N0BBACAC | 4,070 | £317,438 |
| Staladex 11.25mg implant pre-filled syringes | 0803042N0BDAAAF | 240 | £49,440 |
| Prostap PD DCS 1.88mg pdr and solvent for prolonged-rel inj | 0803042N0BBAEAG | 2 | £120 |
| Prostap SR 3.75mg inj vials | 0803042N0BBAAAA | 1 | £75 |
Source: NHSBSA Prescription Cost Analysis · to May 2026 OGL v3.0
Where Leuprorelin acetate is dispensed
The regions and dispensing practices with the highest Leuprorelin acetate volumes.
Top regions
Top dispensing practices
Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.
Compare Leuprorelin acetate with
Other medicines in the same BNF section, by prescribing volume.